U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C34H52N2O2.ClH
Molecular Weight 557.25
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ANIPAMIL HYDROCHLORIDE

SMILES

Cl.CCCCCCCCCCCCC(CCCN(C)CCC1=CC(OC)=CC=C1)(C#N)C2=CC=CC(OC)=C2

InChI

InChIKey=SPIVBBPTKHDDSC-UHFFFAOYSA-N
InChI=1S/C34H52N2O2.ClH/c1-5-6-7-8-9-10-11-12-13-14-23-34(29-35,31-19-16-21-33(28-31)38-4)24-17-25-36(2)26-22-30-18-15-20-32(27-30)37-3;/h15-16,18-21,27-28H,5-14,17,22-26H2,1-4H3;1H

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Protective effect of the new calcium antagonist anipamil against isoprenaline-induced cardionecrosis in rats.
1988 Feb
The persistent sodium current blocker riluzole is antiarrhythmic and anti-ischaemic in a pig model of acute myocardial infarction.
2010 Nov 24
Patents

Patents

Name Type Language
ANIPAMIL HYDROCHLORIDE
Common Name English
BENZENEACETONITRILE, .ALPHA.-DODECYL-3-METHOXY-.ALPHA.-(3-((2-(3-METHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-, HYDROCHLORIDE (1:1)
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
304-988-7
Created by admin on Fri Dec 15 15:03:39 GMT 2023 , Edited by admin on Fri Dec 15 15:03:39 GMT 2023
PRIMARY
EPA CompTox
DTXSID30915673
Created by admin on Fri Dec 15 15:03:39 GMT 2023 , Edited by admin on Fri Dec 15 15:03:39 GMT 2023
PRIMARY
CAS
94313-88-9
Created by admin on Fri Dec 15 15:03:39 GMT 2023 , Edited by admin on Fri Dec 15 15:03:39 GMT 2023
PRIMARY
PUBCHEM
9959416
Created by admin on Fri Dec 15 15:03:39 GMT 2023 , Edited by admin on Fri Dec 15 15:03:39 GMT 2023
PRIMARY
FDA UNII
HX850AM4B2
Created by admin on Fri Dec 15 15:03:39 GMT 2023 , Edited by admin on Fri Dec 15 15:03:39 GMT 2023
PRIMARY